Adverum Biotechnologies

Adverum Biotechnologies

Redwood City, CA
139 Total Employees
Year Founded: 2012

Similar Companies Hiring

Machine Learning • Design • Biotech • Artificial Intelligence
Boston, MA
95 Employees
Virtual Reality • Software • Kids + Family • Healthtech • Gaming • Consumer Web • Biotech
4 Offices
387 Employees
Software • Pharmaceutical • Machine Learning • Biotech • Big Data • Artificial Intelligence • Analytics
11 Offices
63000 Employees

Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary, intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its novel gene therapy candidate, ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022), as a one-time, IVT injection for patients with neovascular or wet age-related macular degeneration. By overcoming the challenges associated with current treatment paradigms for these debilitating ocular diseases, Adverum aspires to transform the standard of care, preserve vision, and create a profound societal impact around the globe.


Adverum Biotechnologies Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site: None
Redwood City, CA